Press release
Dengue Vaccine Market Report Analysis, Research Studies | Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd
DataM Intelligence has published a new research report on "Dengue Vaccine Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/dengue-vaccine-market
The Dengue Vaccine market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.
The Dengue Vaccine Market refers to the global industry focused on the research, development, production, and distribution of vaccines designed to prevent dengue fever, a mosquito-borne viral infection caused by the dengue virus. This market includes vaccines targeting multiple serotypes of the dengue virus, which can cause severe flu-like symptoms and, in some cases, lead to life-threatening complications such as dengue hemorrhagic fever or dengue shock syndrome. The market is driven by the global burden of dengue, particularly in tropical and subtropical regions, and efforts to reduce transmission through vaccination programs. Key players in this market include pharmaceutical companies, research institutions, and public health organizations working towards effective prevention strategies against dengue fever.
Forecast Growth Projected:
The Global Dengue Vaccine Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
List of the Key Players in the Dengue Vaccine Market:
Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd, Vabiotec, Panacea Biotec and Medigen Biologics.
Segment Covered in the Dengue Vaccine Market:
By Product Type: CYD-TDV
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Others
Regional Analysis:
The global Dengue Vaccine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Customization in the report as per your requierments: https://datamintelligence.com/customize/dengue-vaccine-market
Regional Analysis:
The global Dengue Vaccine Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Dengue Vaccine Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Dengue Vaccine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of Dengue Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/dengue-vaccine-market
FAQs
How fast is the Dengue Vaccine Market growing?
The Dengue Vaccine Market will exhibit a CAGR of 10.4% during the forecast period, 2024-2031.
Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dengue Vaccine Market Report Analysis, Research Studies | Sanofi, Panacea Biotec, Biological, E. Limited, GlaxoSmithKline plc, Merck & Co., Takeda Pharmaceutical Company Ltd here
News-ID: 3573377 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Recloser Control Market Size to Reach US$2.64 Billion by 2035, Driven by Distrib …
According to DataM Intelligence, the global recloser control market size is estimated at approximately USD 1.59 billion in 2025 and is projected to reach USD 2.64 billion by 2035, expanding at a CAGR of 5.2% during 2026-2035. The market is benefiting from increasing investment in distribution automation, grid modernization, renewable-energy integration, distributed energy resources (DER), automated fault restoration, cybersecurity and digital utility infrastructure.
Recloser controls are increasingly shifting from conventional…
3D Food Printing Market Size to Reach USD 10.21 Billion by 2035 as Personalized …
According to DataM Intelligence, the global 3D food printing market size was valued at USD 5.358 billion in 2025 and is projected to reach USD 10.21 billion by 2035, expanding at a CAGR of 34.3% during 2026-2035. The 3D food printing market size is gaining attention as food manufacturers, restaurants and healthcare providers explore customized preparation, controlled portions and digitally designed food products.
The 3D food printing industry is moving…
Underground Mining Vehicles Market Size to Reach USD 13.7 Billion by 2035 as Bat …
According to DataM Intelligence, the underground mining vehicles market was valued at USD 7.29 billion in 2025 and is projected to reach USD 13.7 billion by 2035, growing at a CAGR of 6.01% during 2026-2035. Mining companies are changing the way they evaluate underground vehicle fleets. Instead of focusing only on engine power, payload capacity and acquisition cost, operators now consider ventilation expenses, energy efficiency, automation readiness, maintenance requirements and…
Monorail Systems Market Size to Reach USD 14.22 Billion by 2032, as Smart Urban …
According to DataM Intelligence, the global monorail systems market was valued at USD 9.45 billion in 2025 and is projected to reach USD 14.22 billion by 2032, growing at a 6.02% CAGR during the forecast period. Electric propulsion dominates the industry with an 87.8% share, while Asia-Pacific accounts for 42% of global revenue, supported by large-scale urban transit investments and expanding rail infrastructure.
Monorail systems are no longer viewed as…
More Releases for Dengue
Dengue Rapid Test Market To Witness Substantial Growth, 2026-2033| SD Biosensor …
The qualitative latest Research report (2026-2033) on the Dengue Rapid Test Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
➤ Request a Sample Copy (Complete TOC,…
Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to…
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate?
In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,…
Dengue Vaccine Market : An Detailed Overview
Introduction:
Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the…
Dengue Vaccine Market : An Overview
Introduction:
Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent…
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual.
It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like…
